Michael York
Geen lopende functies
Vermogen: 59 629 $ op 31-05-2023
Loopbaan van Michael York
Eerdere bekende functies van Michael York
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| METACRINE, INC. | Comptroller/Controller/Auditor | 31-03-2022 | 24-03-2023 |
| Algemeen Directeur | 01-02-2023 | 24-03-2023 | |
| Financieel Directeur/CFO | 31-03-2022 | 24-03-2023 | |
| Corporate Officer/Principal | 01-12-2021 | 31-03-2022 | |
| President | 01-02-2023 | 24-03-2023 | |
| Bedrijfssecretaris | 01-02-2023 | 24-03-2023 | |
| Treasurer | 31-03-2022 | 24-03-2023 | |
| PHASEBIO PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-06-2018 | 01-11-2021 |
| OREXIGEN THERAPEUTICS, INC. | Corporate Officer/Principal | 01-08-2015 | 01-06-2018 |
| Sente, Inc. | Algemeen Directeur | 01-07-2013 | 01-12-2014 |
| President | 01-07-2013 | 01-12-2014 | |
| SENTÉ Labs | Algemeen Directeur | - | - |
| President | - | - | |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Corporate Officer/Principal | - | - |
Opleiding van Michael York
| San Diego State University | Undergraduate Degree |
| University of Redlands | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 9 |
Operationeel
| Corporate Officer/Principal | 4 |
| Chief Executive Officer | 3 |
| President | 3 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
| Technology Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| PHASEBIO PHARMACEUTICALS, INC. | Health Technology |
| METACRINE, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
| Sente, Inc. | Technology Services |
| SENTÉ Labs |
- Beurs
- Insiders
- Michael York
- Ervaring
